Global Academic Programs 2011 Conference
Draft April 13, 2011
Global Academic Programs 2011 Conference
May 31st – June 2, 2011
Hickey Auditorium and Anderson Conference Hall
Program Agenda
Tuesday, May 31, 2011
8:00 – 8:05 AMOpening Address
Oliver Bogler, Ph.D, Professor of Neurosurgery
Vice President, Global Academic Programs
Keynote Address
8:05 – 9:15 AMTumor Resequencing
Richard Gibbs, Ph.D., Director and Wofford Cain Professor
BCM-HumanGenomeSequencingCenter
Department of Molecular and Human Genetics
BaylorCollege of Medicine
Large-scale Sequencing of Tumors in Hospital AC Camargo
Emmanuel Dias-Neto, Ph.D.
Head, Medical Genomics and Bioinformatics
AC CamargoCancerHospital – Sao Paulo, Brazil
Genomic Sequencing of Human Primary Brain Tumors
Daniel Patrick Cahill, M.D., Ph.D.
Assistant Professor, Neurosurgery
UT M.D.AndersonCancerCenter
Tmprss2: Erg Gene-Fusion Promotes Epithelial to Mesenchymal Transition in Immortalized Human Prostate Transition Epithelial Cells
Raanan Berger, M.D., Ph.D.
Senior Oncologist
ShebaMedicalCenter – Tel Hashomer, Israel
High-Throughput Sequencing-Based Small RNA Identification for Biomarker Discovery in Oral Squamous Cell Carcinoma
Patricia Severino, Ph.D.
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
9:15 – 10:30 AM Biomarkers and Gene Expression
Session Chair, Kenneth D. Aldape, M.D.
Professor, Pathology
UT M.D.AndersonCancerCenter
IDH1
Andreas Von Deimling, M.D.
GermanCancerResearchCenter (DKFZ) – Heidelberg, Germany
Molecular Aspects of Breast Cancer: Insights From Gene Expression Studies
Dirce Carraro, Ph.D.
Coordinator of Nucleic Acid Bank
Head, Laboratory of Molecular Biology
AC Camargo Cancer Hospital – Sao Paulo, Brazil
TP53 Mutations as Biomarkers for Cancer Detection, Prognosis and Therapy
Pierre Hainaut, Ph.D.
Head, Molecular Carcinogenesis
International Agency for Research on Cancer – Lyon, France
Pharmacogenomic Biomarker Development in Gastric Cancer
Sun Young Rha, M.D.
YonseiCancerCenter – Seoul, Korea
The Wilms’ Tumor Initiating Cell Is An NCAM Cell Enriched for ALDH1 Activity and Possessing Renal Stem Cell Characteristics That Can Be Targeted in Vivo
Benjamin Dekel, M.D.
Professor
Sheba Medical Center – Tel Hashomer, Israel
Oncogenetics at AlbertEinsteinHospital: Patient Care, Education and Research
Fernanda Teresa de Lima, M.D., Ph.D.
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
10:30 – 10:45 AMCoffee Break
10:45 – 12:30 PMDrug and Technology Research and Development
Session Chair, Garth Powis, DPHIL
Professor and Chair, Experimental Therapeutics
UT M.D.AndersonCancerCenter
*Young Investigator Travel Award*
MRI for Depiction of Subtle BBB Opening in Glioblastoma Multiforme Patients
Yael Mardor, M.D.
Sheba Medical Center – Tel Hashomer, Israel
KLOTHO: From Hormone to Novel Cancer Therapy
Ido Wolf, M.D.
Senior Oncologist
ShebaMedicalCenter – Tel Hashomer, Israel
STIL Regulates Mitotic Entry and Centrosomal Formation Through Regulation of the CHFR Tumor Suppressor Protein
Shai Izraeli, M.D.
Associate Professor
ShebaMedicalCenter – Tel Hashomer, Israel
Good Clinical Practice (GCP) Center in China
Yuanki Shi, M.D.
Professor and Vice President
ChineseAcademy of Medical Sciences (CAMS) Cancer Institute & Hospital – Beijing, China
*DKFZ SINF Award*
Intensity modulated particle therapy
Uwe Oelfke, Ph.D.
Medical Physics, Radiation Therapy
GermanCancerResearchCenter (DKFZ) – Heidelberg, Germany
Radhe Mohan, Ph.D.
Professor, Radiation Physics – Patient Care
UT M.D.AndersonCancerCenter
12:30 – 2:00 PMLunch
GAP Business Meeting (all are invited)
- GAP Network and GAP Connect
- Sister Institution Network Fund (SINF)
- GAP 2012 Conference (Oslo, Norway)
Hickey Auditorium
2:00 – 4:30 PM Global Clinical Trials Research
Session Chair, Hagop M. Kantarjian, M.D.
Professor and Chair, Leukemia
Associate VicePresident for Clinical Research, GAP
2:00 – 2:15 PMNew Drugs, Pathways, Shared Protocols, Infrastructure
Hagop M. Kantarjian
2:15 – 2:30 PMInflammatory Breast Cancer Registry
Other site tbc
Other person tbc
Ricardo Alvarez, M.D.
2:30 – 2:45 PMTrial title tbc
ChineseUniversity of Hong Kong – Hong Kong, China
Anthony Chan, M.D.
Kian Ang, M.D.
2:45 – 3:00 PMInternational Validation Study of Post-Chemotherapy Viable NSGCT
Institute Gustave Roussy – Villejuif, France
Karim Fizazi, M.D.(tbc)
Lance Pagliaro, M.D.
3:00 – 3:15 PMClinical Trials: Starting a Local Network and Collaboration with M.D.AndersonCancerCenter
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
Oren Smaletz, M.D.
MDACC person tbc
3:15 – 3:30 PMDevelopment of IND Based International Investigator Breast Cancer Clinical Trials
Tokyo Oncology Consortium – Tokyo, Japan
Teruo Yamauchi, M.D.
Naoto Ueno, M.D. Ph.D.
3:30 – 3:45 PMMDACC / INEN Prior and Current Breast Cancer Trials
National Cancer Institute of Peru – Lima, Peru
Tatiana Vidaurre, M.D.
Vicente Valero, M.D.
3:45 – 4:00 PMPhase I Study of Ofatumumab for Purging in Large CellLymphoma
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
Clinica Alemana – Santiago, Chile
Nelson Hamerschlak, M.D.,Ph.D
Alejandro Majlis, M.D.
Marcos de Lima, M.D.
4:00 – 4:15 PMConservative Surgery for Women with Low-risk, Early Stage Cervical Cancer
Clinica Alemana – Santiago, Chile
CA person to be determined
Kathleen Schmeler, M.D.
4:15 – 4:30 PMA Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Patients with Early Stage Cervical Cancer
Instituto de Cancerologia Las Americas – Medellin, Colombia
Rene Pareja, M.D.
Pedro Ramirez, M.D.
A Vision for the Future - Multimedia Structured Reporting
David Vinning, M.D.
Professor, Diagnostic Radiology
UT M.D.AndersonCancerCenter
4:30 – 5:00 PMCollaboration Discussion
5:00 – 5:30 PMWelcome Address
John Mendelsohn, M.D.
President
UT M.D.AndersonCancerCenter
5:30 – 7:30 PMWelcome Reception
Anderson Conference Hall
Wednesday, June 1, 2011
8:00 – 10:00 AMPlenary Session - Signal Transduction
Mien-Chie Hung, Ph.D.
Professor and Chair, Molecular and Cellular Oncology
UT M.D.AndersonCancerCenter
Cancer Biomarkers in Neuro-Oncology
Rui Reis, Ph.D.
Director of Research and Coordinator of Molecular Oncology Research Lab
BarretosCancerHospital – Barretos, Brazil
Title to be decided
Hideyuki Saya, M.D.,Ph.D.
Professor, Division of Gene Regulation
Institute for Advanced Medical Research(IAMR)
School of Medicine, KeioUniversity – Tokyo, Japan
Endocytic Protein: Master Regulator of Cell Signalling
Guoguang Ying, Ph.D.
Professor, Deputy Director
Tianjin Cancer Research Institute – Tianjin, China
Epigenetic Regulation of Neuron Differentiation From Mesenchymal Stem Cells By Polycomb Group Protien EZH2
Alan Yung-Luen Yu, Ph.D.
Associate Research Fellow, Center for Molecular Medicine
China Medical university Hospital – Taichung, Taiwan
8:00 – 10:00 AMSister Institution Network Fund (SINF)Program Committee Meeting(only your designated SINF program committee member can attend – this a closed meeting)
10:00 – 10:15 AMCoffee Break
Simultaneous Break-Out Sessions
10:15 – 1:00 PM Frontiers In Gastrointestinal and Hepatobiliary Cancers
Session Chair, Lopa Mishra, M.D.
Professor and Chair, Gastroenterology, Hepatology & Nutrition
UT M.D.AndersonCancerCenter
Molecular Targets and Opportunities: Tumor Initiating Stem Cells In Gastrointestinal and Hepatocellular Cancer
Lopa Mishra, MD
Chair and Professor, Department of Gastroenterology, Hepatology, & Nutrition
The University of Texas MD AndersonCancerCenter
Education and Imaging in Liver and Pancreatic Cancers in India at a GEMS Institute
C.E. Eapen, MD
Professor of Gastroenterology and Hepatology
ChristianMedicalCollege, Vellore, India
Hepatocellular Cancer: A Global Perspective
Shiv Sarin, MD
Chairman of the Medical Council of India (MCI)
Professor and Head, Department of Hepatology, & Director, Institute of Liver and Biliary Sciences (ILBS)
GB PantHospital, New Delhi, India
Biliary Cancers: New Advances
Ivan Roa, MD
Chief, Department of Pathology
Clinica Alemana de Santiago – Santiago, Chile
Colon Cancer – High Risk Cancer Registry and Advances in FAP
Patrick Lynch, JD, MD
Professor, Department of Gastroenterology, Hepatology, & Nutrition
The University of Texas MD AndersonCancerCenter
New Horizons in Cancer Prevention – for GI and Hepatobiliary Cancers
Powel Brown, MD, PhD
Chair and Professor, Clinical Cancer Prevention
The University of Texas MD AndersonCancerCenter
Laparasocopy Versus Robotic TME for Rectal Cancer: A Prospective Randomized Trial
Antonio Luiz de Vasconcellos Macedo, M.D.
General Surgeon, President, Oncology Council
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
Enigmatic of Low Incidence of GI Cancers in Indians
Mohandas Mallath, M.D.
Convener, GI Cancer – Disease Management Group and Director, Centre for Epidemiology
Tata Memorial Centre – Mumbai, India
Response Predictors for Neoadjuvant Treatment in Rectal Cancer
Samuel Aguiar Jr, M.D., Ph.D.
Surgical Oncology
AC Camargo Hospital – Sao Paulo, Brazil
Chemoradiotherapy For Colorectal Cancer: Results From Prospective Randomized Nordic Trials
Kjell Magne Tveit, M.D.
Professor and Head of Department of Oncology
OsloUniversityHospital – Olso, Norway
Surgical Treatment of Hepatocellular Carcinoma
Qiang Li, M.D.
Vice President
Tianjin Medical University Cancer Institute – Tianjin, China
Collaboration Discussion
10:15 – 12:30 PMBreast Cancer
Session Chair, Banu K. Arun, M.D.
Professor, Breast Medical Oncology
UT M.D.AndersonCancerCenter
The Application of a Modified Gail Model in Estimating the Risk for Developing Breast Cancer Among Jordanian Women
Luna Al-Zaru, M.D.
Director, Office of clinical Research and Cancer Registry
KingHusseinCancerCenter – Amman, Jordan
The Glucagon-like Peptide (GLP)-1 and Exendin-4: Activators of cAMP and Novel Growth Inhibitors of Breast Cancer Cells
Tami Rubinek, Ph.D.
ShebaMedicalCenter – Tel Hashomer, Israel
Higher Expression of Androgen Receptor as a Significant Predictor for Better Endocrine-responsiveness in Estrogen Receptor-Positive Breast Cancers
Se-ho Park, M.D., Ph.D.
Surgery
YonseiUniversityMedicalCenter – Seoul, South Korea
Effects of An mTOR Inhibitor RAD001 on Human Breast Cancer Stem Cells In Vitro and In Vivo
Jin Zhang, M.D.
Director, BreastCancerCenter
Tianjin Medical University Cancer Institute and Hospital – Tianjin, China
Breast Cancer Patient Satisfaction With Reconstruction: Arab Women Experience
Firas F. AL-Ahmad, MD, MRCS
Surgical Oncology Fellow, Department of Surgery
KingHusseinCancerCenter – Amman, Jordan
Collaboration Discussion
10:15 – 12:30 PMHematologic Malignancies
Session Chair, Marcos J. de Lima, M.D.
Professor, Stem Cell Transplantation
UT M.D.AndersonCancerCenter
Implications of Microenvironment Interactions in Multiple Myeloma (MM) and Chronic Lymphocytic Leukemia (CLL): The Role of CXCR4/CXCL12 Chemokine Pathway
Katia Beider, Ph.D.
ShebaMedicalCenter – Tel Hashomer, Israel
Oral or IV BFLU as a Conditioning Regimen for Myeloid Diseases at Albert Einstein
Fabio Kerbauy, M.D.
Hematology
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
Azacitidine 100mg Fixed Daily Dose for the Treatment and Retreatment of Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia
Su-Peng Yeh, M.D.
Associate Professor
ChinaMedicalUniversityHospital – Taichung, Taiwan
A Randomised, Open-Label, Multicentre Phase III Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone (VcRCAP) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (RCHOP) in Patients With Newly Diagnosed Mantle Cell Lymphoma Who Are Not Eligible for a Bone Marrow Transplant
Huanqing Wang, M.D.
Director, Lymphoma Department
Tianjin MedicalUniversity Cancer Institute and Hospital – Tianjin, China
*DKFZ SINF Award*
Deciphering the Role of Non-coding RNA in Chronic Lymphocytic Leukemia
Thorsten Zenz, Translational Oncology
GermanCancerResearchCenter (DKFZ) – Heildelberg, Germany
George A. Calin, M.D., Ph.D.
Associate Professor, Experimental Therapeutics
UT M.D.AndersonCancerCenter
Research Profile for the Lymphoma Program at the NorwegianRadiumHospital
Harald Holte, M.D.
Professor,
Norwegian Cancer Consortium – Oslo, Norway
Title to be determined
Jose Francisco Tomas, M.D.
Medical Director and Chief of Hematology
Centro Oncologico M.D. Anderson International Espana – Madrid, Spain
R-ESHAP As Salvage Therapy In Chinese Patients With Relapsed Or Refractory Diffuse Large B-cell Lymphoma: A Prospective Phase II Study
Kai Xue, M.D.
??
FudanUniversityCancerHospital – Shanghai, China
Collaboration Discussion
10:15 – 12:30 PMPain and Supportive Care
Session Chairs
Thomas W. Feeley, M.D.
Professor and Division Head, Anesthesiology and Critical Care
UT M.D.AndersonCancerCenter
Eduardo Bruera, M.D.
Professor and Chair, Palliative Care & Rehabilitation Medicine
Pain Management Experience at KingHusseinCancerCenter (KHCC)
Hussein Abu Khudair, M.D.
Chairman, Department of Anesthesia & Pain Management
KingHusseinCancerCenter – Amman, Jordan
Pain Management at M.D.AndersonCancerCenter
Larry C. Driver, M.D.
Chair Ad Interim and Professor, Pain Medicine
UT M.D.AndersonCancerCenter
Supportive and Palliative Care at M.D.AndersonCancerCenter
David Hui, M.D.
Assistant Professor, Palliative Care and Rehabilitation Medicine
UT M.D.AndersonCancerCenter
Collaboration Discussion
10:15 – 12:30 PM Tumor Resequencing Workshop
(To be held at the GenomeCenter at Baylor College of Medicine)
David A. Wheeler, Ph.D.
AssociateProfessor, HumanGenomeSequencingCenter
Department of Molecular & Human Genetics
BaylorCollege of Medicine
Collaboration Discussion
12:30 – 2:00 PM Lunch at Trevisio
Directors’ Luncheon
2:00 – 3:45 PMPlenary Session – Personalized Medicine
Evolution of Personalized Medicine In Non-Small Cell Lung Cancer (NSCLC)
Edward S. Kim, M.D., Associate Professor
Thoracic / Head & Neck Medical Oncology
UT M.D.AndersonCancerCenter
Talk title tbc
Thomas Tursz, M.D.
Former Director
Institute Gustave Roussy – Villejuif, France
The WIN Symposium
Vladimir Lazar, M.D., Ph.D.
Institute Gustave Roussy - Villejuif, France
Clinical Responses Using Adoptive Transfer of Young Tumor Infiltrating Lymphocytes in Metastatic Melanoma Patients
Michal J. Besser, Ph.D.
Head of Clinical Lab
ShebaMedicalCenter – Tel Hashomer, Israel
3:30 – 3:45 PM Coffee Break
3:45 – 5:15 PMSimultaneous Break-Out Sessions
3:45 – 5:15 PMGenitourinary Malignancies
Session Chair, Deborah Kuban, M.D.
Professor, Radiation Oncology
UT M.D.AndersonCancerCenter
The ProtonTherapyCenter at M.D.AndersonCancerCenter
Speaker tbc
Associate Professor, Radiation Oncology
UT. M.D.AndersonCancerCenter
Pentafecta: A New Concept for Reporting Outcomes of Robot-Assisted Laparoscopic Radical Prostatectomy
Rafael Ferreira Coelho, M.D.
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
Ethnic Differences inTreating mRCC with Targeted Agents
Sun Young Rha, M.D.
??
YonseiCancerCenter
Prognostic Molecular Markers in Non-Muscle Invasive Bladder Cancer: Results and Perspectives
Mario Fernandez, M.D.
Urology
Clinica Alemana – Santiago, Chile
*Young Investigator Travel Award*
Association of Polymorphisms and Expression of ERCC1 and XPA With The Response of Patients With Testicular Germ Cell Tumors Treated With Cisplatin
Julia R. Mendoza Perez, M.D.
National Cancer Institute (INCan) – Mexico City, Mexico
Collaboration Discussion
3:45 – 5:15 PMHead & Neck/Thoracic Cancers
Session Chair, Merrill S. Kies, M.D.
Professor, Thoracic/Head & Neck Medical Oncology
UT M.D.AndersonCancerCenter
Epigenetic Markers in Saliva for Diagnosis and Prognosis of Head and Neck Cancer Patients
Andre Lopes Carvalho, M.D., Ph.D.
Research Director, Chief, Head & Neck Cancers
BarretosCancerHospital – Barretos, Brazil
AC Camargo Hospital Experience in the Treatment of Oral Cancer
Luiz Paulo Kowalski, M.D., Ph.D.
Director, Head & Neck Surgery and Otorhinolaryngology
AC Camargo Cancer Hospital – Sao Paulo, Brazil
The Susceptibility Genes of NasoPharyngeal Carcinoma
Jin-Xin Bei, M.D.
Associate Professor
SunYat-SenUniversityCancerCenter – Guangzhou, China
Novel Therapeutic Strategies in Nasopharyngeal Cancer
Herbert Loong, M.D.
Honorary Clinical Tutor
ChineseUniversity of Hong Kong – Hong Kong, China
Lung Cancer in Brazil: Characteristics & Challenges
Ricardo Sales dos Santos, M.D.
Head, Minimally Invasive Thoracic Surgery
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
The Cyberknife Treatment for Early Stage Lung Cancer
Yuan Zhiyong, M.D.
Director, Radiotherapy Department
Tianjin Medical University Cancer Institute and Hospital – Tianjin, China
Collaboration Discussion
3:45 – 5:15 PMGynecologic Malignancies
Session Chair, Pedro Tomas Ramirez, M.D.
Associate Professor, Gynecologic Oncology
UT M.D.AndersonCancerCenter
*Young Investigator Travel Award*
The Biphasic Role of NF-kB in Tumor Progression and Chemoresistance of Ovarian Cancer
Gong Yang
FudanUniversityShanghaiCancerCenter – Shanghai, China
3:45 - 3:50 PMIntroduction
Kathleen M. Schmeler, M.D.
Assistant Professor, Gynecologic Oncology
UT M.D.AndersonCancerCenter
3:50 - 4:10 PMPhase III International Randomized Trial of Open Versus Minimally Invasive Surgery for Cervical Cancer
Pedro T Ramirez, M.D.
Assistant Professor, Gynecologic Oncology
UT M.D.AndersonCancerCenter
4:10 - 4:20 PMProspective Study of Conservative Surgery for Early Stage Cervical Cancer
Kathleen M. Schmeler, M.D.
Assistant Professor, Gynecologic Oncology
UT M.D.AndersonCancerCenter
4:20 – 4:30 PMA Pilot Study Using Optimal Imaging for Cervical Cancer Screening in Brazil
Jose Humberto Fregnani, M.D.
Chief, Gynecologic Oncology
BarretosCancerHospital – Barretos, Brazil
4:30 – 4:40 PMChallenges of Prospective, International Multi-Institutional Trials
Kathleen M. Schmeler, M.D.
Assistant Professor, Gynecologic Oncology
UT M.D.AndersonCancerCenter
4:40 – 5:00 PMCollaborations with MD Anderson: The Collaborator's Perspective
Rene Pareja, M.D., Gynecology
Instituto de Cancerologia IDC Las Americas – Medellin, Colombia
David Cantu, M.D., Gynecology
Instituto Nacional de Cancerologia – Mexico City, Mexico
Aldo Lopez, M.D., Gynecology
Instituto Nacional de Enfermedades Neoplasicas – Lima, Peru
5:00 – 5:15 PMCollaboration Discussion
5:15 – 7:00 PMWine and Cheese Reception – Hickey Foyer
Poster Session (keep posters up thru next morning)
Thursday, June 2, 2011
8:00 – 10:30 AMPlenary Session – Cancer Prevention
Ernest Hawk, M.D., VP, Cancer Prevention & Population Sciences
UT M.D.AndersonCancerCenter
8:00 – 8:15 AMChallenges In Cancer Prevention Programs: Resource Constrained Settings
Surenda S. Shastri, M.D.
Head, Preventive Oncology
Tata Memorial Centre – Mumbai, India
8:15 – 8:30 AMIs Community Intervention in Breast Cancer Screening in Brazil Feasible?
Edmundo Mauad, M.D., Ph.D.
Medical Director and Head of Prevention
BarretosCancerHospital – Barretos, Brazil
8:30 – 8:45 AMHPV Vaccination: Preliminary Results of a School-Based Project Designated b y the Barretos Cancer Hospital, Brazil
Jose Humberto Fregnanai, M.D., Ph.D.
Head, Gynecologic Oncology
Barretos Cancer Hospital – Barretos, Brazil
8:45 – 9:00 AMInternational Networks for Global Prevention Research: The Next Generation
Pierre Hainaut, Ph.D.
Head of Molecular Carcinogenesis
International Agency for Research on Cancer – Lyon, France
9:00 – 9:15 AMCoffee Break
9:15 – 9:30 AMSmokingPrevention in Youth: A Spectrum of Intervention Approaches
Karen Sue Calabro,Ph.D.
Population Sciences Fellow
UT M.D.AndersonCancerCenter
Alexander V. Prokhorov, M.D., Ph.D.
Professor and Director, Tobacco Outreach Education Program
Director, eHealth Technology Program
Department of Behavioral Science
Division of Cancer Prevention and Population Sciences
UT M.D.AndersonCancerCenter
9:30 – 9:45 AM The Framework Convention Treaty andTobacco Policies Around the World
Joel S. Dunnington, M.D.
Professor, Diagnostic Radiology, Director, GI Radiology
UT M.D.AndersonCancerCenter
9:45 – 10:00 AMSmokingCessation in Cancer Patients and Other Chronic Disease Populations
Ellen R. Gritz, Ph.D.
Professor and Chair, Behavioral Science
UT M.D.AndersonCancerCenter
10:00 – 10:30 AMCollaboration Discussion
10:30 – 10:45 AMCoffee Break
10:45 – 12:30 PMSimultaneous Break–Out Sessions
Survivorship
Session Chair, Michele Forman, PH.D.
Professor, Epidemiology
UT M.D.AndersonCancerCenter
Developing a Cancer Survivorship Programme at TataMemorialHospital Using ACT (After Completion Therapy) Clinic for Long Term Survivors of Childhood Cancer as a Model
Purna A. Kurkure, M.D.
Professor & Head of Pediatric Oncology, Coordinator, ACT Clinic
TataMemorialHospital – Mumbai, India
The Problems Caused By Curing Testicular Cancer (TC) and Survivorship
Sophie Fossa, M.D.
Professor
The RadiumHospital – Oslo, Norway
Fertility After Childhood Cancer: A Registry-based Study
Milada Cvancarova, M.Sc.
Statistician
The RadiumHospital – Oslo, Norway
Title to be determined
Guadalupe Palos, MSW, DRPH, BS, LMSW, RN (tbc)
Manager, Clinical Protocol Administration, Cancer Survivorship
UT M.D.AndersonCancerCenter
Collaboration Discussion
10:45 – 12:30 PMInternational Perspective on Integrative Oncology
Session Chair, Lorenzo Cohen, Ph.D.
Professor, General Oncology
UT M.D.AndersonCancerCenter
Chinese Medicine in Oncology: Clinical Care, Research and International Collaboration
Zhiqiang Meng, M.D.
Department of Integrative Oncology
FudanUniversityCancerCenterHospital – Shanghia, China
Holistic Dimensions of Yoga for Breast Cancer: An Update on Research
H.R. Nagemdra
R. Nagaratna
SVYASAYogaUniversity – Bangalore, India
Integrative Medicine Research: Mind and Body Research – Challenges and Opportunities
Paulo de Tarso Lima, M.D.
Integrative and Complementary Medicine
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
Collaboration Discussion
10:45 – 12:30 PMGlobal Challenges and Opportunities Facing Women Oncologists and Cancer Researchers: A Conversation
Elizabeth L. Travis, Ph.D., FASTRO
Associate VP, Women’s Faculty Programs